In vitro diagno substances, reagents
Ended Awarded
- Contract number
- HHSN26300234
- Awardee
-
Qiagen, LLC UEI W2GLKC92ZH73 Part of Qiagen N.V.
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,996
Award facts
- Contract value 100% obligated
- $14,995.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Valencia, CA 91355, USA
Award details come from SAM.gov/FPDS.
About this award
Qiagen, LLC received a $14,995.70 firm fixed-price Blanket Purchase Agreement (BPA) call award from the Office of the Director (a civilian federal agency) on December 3, 2009, for in vitro diagnostic substances and reagents. The contract, with an ultimate completion date of December 31, 2009, was performed at Qiagen's location in Valencia, California. No set-aside designation was used for this award, reflecting the company's ability to compete in the open federal marketplace. This call represents a task order or drawdown against a larger BPA vehicle that enables the agency to efficiently procure molecular diagnostics products and specialized reagents on an as-needed basis.
Qiagen, LLC is a subsidiary of Qiagen N.V., a multinational biotechnology company headquartered in the Netherlands that specializes in molecular diagnostics, sample preparation technologies, and bioinformatics solutions. The company serves multiple federal agencies including the National Institutes of Health, Centers for Disease Control and Prevention, Department of Veterans Affairs, and Department of Defense, providing products such as DNA/RNA extraction kits, digital PCR systems, tuberculosis testing reagents, and diagnostic equipment. Through its portfolio of indefinite delivery vehicles and BPAs across federal agencies, Qiagen maintains established relationships that facilitate rapid procurement of critical laboratory and diagnostic products supporting biomedical research, public health, healthcare, and law enforcement initiatives.
Quick answers
Who was awarded contract HHSN26300234?
HHSN26300234 was awarded to Qiagen, LLC by Office of the Director (National Institutes of Health) on December 3, 2009.
How much is contract HHSN26300234 worth?
The government has obligated $14,996 on HHSN26300234.
Is contract HHSN26300234 an order under another contract?
Yes. HHSN26300234 is a BPA call under HHSN263200100054095B, a blanket purchase agreement.
Was contract HHSN26300234 competed?
The extent of competition for HHSN26300234 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award